153 related articles for article (PubMed ID: 22099424)
21. Low risk for hepatitis C in hemophiliacs given a high-purity, pasteurized factor VIII concentrate. International Study Group.
Mannucci PM; Schimpf K; Brettler DB; Ciavarella N; Colombo M; Haschke F; Lechner K; Lusher J; Weissbach G
Ann Intern Med; 1990 Jul; 113(1):27-32. PubMed ID: 2112352
[TBL] [Abstract][Full Text] [Related]
22. A multicenter study of viral hepatitis in a United States hemophilic population.
Troisi CL; Hollinger FB; Hoots WK; Contant C; Gill J; Ragni M; Parmley R; Sexauer C; Gomperts E; Buchanan G
Blood; 1993 Jan; 81(2):412-8. PubMed ID: 7678517
[TBL] [Abstract][Full Text] [Related]
23. Epidemiology of hemophilia and of HIV infection in Italy. GICC. Gruppo Italiano Coagulopatie Congenite.
Ghirardini A; Schinaia N; Chiarotti F; De Biasi R; Rodeghiero F; Binkin N
J Clin Epidemiol; 1994 Nov; 47(11):1297-306. PubMed ID: 7722566
[TBL] [Abstract][Full Text] [Related]
24. National survey of human immunodeficiency virus infection in Italian hemophiliacs: 1983-1987. The Medical-Scientific Committee of the Fondazione dell'Emofilia.
Gringeri A; Mannucci PM
Ric Clin Lab; 1988; 18(4):275-80. PubMed ID: 3150122
[TBL] [Abstract][Full Text] [Related]
25. Is time to treat for HCV all the HIV/HCV co-infected hemophiliacs?
Franchini M
Hematology; 2006 Jun; 11(3):209-13. PubMed ID: 17325964
[TBL] [Abstract][Full Text] [Related]
26. Hepatitis C contributes to liver disease in children and adolescents with hemophilia.
Wagner N; Rotthauwe HW
Klin Padiatr; 1994; 206(1):40-4. PubMed ID: 7512169
[TBL] [Abstract][Full Text] [Related]
27. Review of the hepatitis A epidemics in hemophiliacs in Europe.
Vermylen J; Peerlinck K
Vox Sang; 1994; 67 Suppl 4():8-11; discussion 24-6. PubMed ID: 7831867
[TBL] [Abstract][Full Text] [Related]
28. The management of hemophilia in elderly patients.
Franchini M; Tagliaferri A; Mannucci PM
Clin Interv Aging; 2007; 2(3):361-8. PubMed ID: 18044186
[TBL] [Abstract][Full Text] [Related]
29. HIV, HBV and HCV seropositivity in hemophiliacs.
Chow MP; Lin CK; Lin JS; Chau WK; Ho CH; Chen SY; Lee SH; Yung CH
Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1991 Nov; 24(4):339-44. PubMed ID: 1726973
[TBL] [Abstract][Full Text] [Related]
30. Antiviral therapy for HCV in hemophilia A patients with HIV-1 co-infection.
Xiao H; Chen J; Wang J; Li J; Yang F; Lu H
Medicine (Baltimore); 2019 Jul; 98(30):e16524. PubMed ID: 31348267
[TBL] [Abstract][Full Text] [Related]
31. Cancers in patients with hemophilia: a retrospective study from the Italian Association of Hemophilia Centers: a rebuttal.
Shetty S; Ghosh K
J Thromb Haemost; 2012 Jun; 10(6):1200-1;author reply 1201-2. PubMed ID: 22497975
[No Abstract] [Full Text] [Related]
32. Clinical burden of hemophilia in older adults: Beyond bleeding risk.
Hodroj MH; El Hasbani G; Al-Shamsi HO; Samaha H; Musallam KM; Taher AT
Blood Rev; 2022 May; 53():100912. PubMed ID: 34887154
[TBL] [Abstract][Full Text] [Related]
33. Update on chronic hepatitis C in hemophiliacs.
Franchini M; Capra F; Tagliaferri A; Rossetti G; De Gironcoli M; Rocca P; Aprili G; Gandini G
Haematologica; 2002 May; 87(5):542-9. PubMed ID: 12010670
[TBL] [Abstract][Full Text] [Related]
34. The natural history of chronic hepatitis C in a cohort of HIV-negative Italian patients with hereditary bleeding disorders.
Franchini M; Rossetti G; Tagliaferri A; Capra F; de Maria E; Pattacini C; Lippi G; Lo Cascio G; de Gironcoli M; Gandini G
Blood; 2001 Sep; 98(6):1836-41. PubMed ID: 11535518
[TBL] [Abstract][Full Text] [Related]
35. Acquired immunodeficiency syndrome-associated non-Hodgkin's lymphomas and other malignancies in patients with hemophilia.
Ragni MV; Belle SH; Jaffe RA; Duerstein SL; Bass DC; McMillan CW; Lovrien EW; Aledort LM; Kisker CT; Stabler SP
Blood; 1993 Apr; 81(7):1889-97. PubMed ID: 8461474
[TBL] [Abstract][Full Text] [Related]
36. Hepatitis C virus/human immunodeficiency virus coinfection in hemophiliacs: high rates of sustained virologic response to pegylated interferon and ribavirin therapy.
Mancuso ME; Rumi MG; Aghemo A; Santagostino E; Puoti M; Coppola A; Colombo M; Mannucci PM
J Thromb Haemost; 2009 Dec; 7(12):1997-2005. PubMed ID: 19799716
[TBL] [Abstract][Full Text] [Related]
37. Hepatitis C virus is related to progressive liver disease in human immunodeficiency virus-positive hemophiliacs and should be treated as an opportunistic infection.
Lesens O; Deschênes M; Steben M; Bélanger G; Tsoukas CM
J Infect Dis; 1999 May; 179(5):1254-8. PubMed ID: 10191232
[TBL] [Abstract][Full Text] [Related]
38. Comparison of the rates of joint arthroplasty in patients with severe factor VIII and IX deficiency: an index of different clinical severity of the 2 coagulation disorders.
Tagariello G; Iorio A; Santagostino E; Morfini M; Bisson R; Innocenti M; Mancuso ME; Mazzucconi MG; Pasta GL; Radossi P; Rodorigo G; Santoro C; Sartori R; Scaraggi A; Solimeno LP; Mannucci PM;
Blood; 2009 Jul; 114(4):779-84. PubMed ID: 19357395
[TBL] [Abstract][Full Text] [Related]
39. Comparison of GB virus C, HIV, and HCV infection markers in hemophiliacs exposed to non-inactivated or inactivated factor concentrates.
Kupfer B; Ruf T; Matz B; Nattermann J; Spengler U; Rockstroh JK; Brackmann HH; Blümel J; Tacke M; Kaiser R
J Clin Virol; 2005 Sep; 34(1):42-7. PubMed ID: 16087123
[TBL] [Abstract][Full Text] [Related]
40. Treatment of hepatitis C in hemophiliacs.
Franchini M; Nicolini N; Capra F
Am J Hematol; 2006 Sep; 81(9):696-702. PubMed ID: 16838339
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
